To provide further evidence for the contribution of endogenous D-serine to AD progression and the potential of AD treatment by SRR regulation, we generated APPKI-SRRKO mice by crossing APPKI mice with SRRKO mice and examined effects on AD pathology. The gene discussed is SRR; the disease is Alzheimer disease.